NC

Niranjana Chandappa Poojari

Active Director Designated Partner DIN 07742157
DIN 07742157 First appointment Feb 2017 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Feb 2017
Shareholding value •••• Premium profile

About Niranjana Chandappa Poojari

Data last updated:

Niranjana Chandappa Poojari has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Avigna Learning Academy Llp and Xenocor Pharmalab Private Limited. Formerly with 3 companies, such as Stellence Pharmscience Private Limited and Chiron Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹9.05 Cr; the largest is Xenocor Pharmalab Private Limited at ₹8.98 Cr (FY 2024).

DIN 07742157
Primary Designation Designated Partner
First Appointment 23 Feb 2017
Oldest Company Age 21 yrs
Largest company Xenocor Pharmalab Private Limited · ₹8.98 Cr (FY 2024)
Combined revenue ₹9.05 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenocor Pharmalab Private Limited U29299KA2007PTC042079
Director28 Mar 20222007₹8.98 Cr (FY 2024)Active
Director21 May 20212021₹7.4 Lakh (FY 2024)Active
Director30 May 20232005–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20171992₹29.16 Cr (FY 2022)Under Cirp
Chiron Lifescience Private Limited U24239KA2017PTC100834
Director23 Feb 20172017–Active
Designated Partner20 Oct 20202010₹32 Lakh (FY 2020)Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avigna Learning Academy Llp
Xenocor Pharmalab Private Limited
Avigna Learning Academy Private Limited
East West Handling And Distribution Private Limited
Premium access

Shareholding and investment profile for Niranjana Chandappa Poojari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niranjana Chandappa Poojari

Niranjana Chandappa Poojari has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Avigna Learning Academy Llp and Xenocor Pharmalab Private Limited. Formerly with 3 companies, such as Stellence Pharmscience Private Limited and Chiron Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹9.05 Cr; the largest is Xenocor Pharmalab Private Limited at ₹8.98 Cr (FY 2024).

Niranjana Chandappa Poojari is associated with 3 companies as Designated Partner and Director, including Xenocor Pharmalab Private Limited (₹8.98 Cr), Avigna Learning Academy Private Limited (₹7.4 Lakh), East West Handling And Distribution Private Limited.

Niranjana Chandappa Poojari has expertise in General Business.

Niranjana Chandappa Poojari has 9 years in corporate governance.

By reported revenue, the largest current company of Niranjana Chandappa Poojari is Xenocor Pharmalab Private Limited, with revenue of ₹8.98 Cr (FY 2024).

The 2 current companies of Niranjana Chandappa Poojari that report revenue have a combined latest revenue of ₹9.05 Cr.

Niranjana Chandappa Poojari currently holds positions at 3 companies: Xenocor Pharmalab Private Limited (₹8.98 Cr), Avigna Learning Academy Private Limited (₹7.4 Lakh), East West Handling And Distribution Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available